Medical researchers discuss liver fibrosis and body temperature regulation

Medical researchers are highlighting critical aspects of human physiology and disease progression. Rubén Nogueiras, a researcher at CiMUS, addressed the risks of metabolic liver disease, noting that approximately 40% of the global population may be in the early stages of the condition. He warned that between 5% and 7% of those individuals could develop liver fibrosis, a serious stage where increased liver stiffness impairs organ function.

Nogueiras discussed the potential role of resmetirom, a medication that targets thyroid hormone beta receptors to promote fatty acid oxidation and mitochondrial formation, which may reduce oxidative stress in liver tissue. He emphasized the difficulty of early detection due to the liver being a ‘silent’ organ.

In a separate scientific discussion, researchers Ramón A. Piñol and Eduardo Rivero Sigarroa explored the strict regulation of human body temperature. They explained that while humans are subject to environmental climate changes, the autonomic nervous system maintains internal stability. Piñol noted that thermoregulation is a metabolic byproduct of cellular activity and discussed how the central nervous system maps connections between temperature, energy expenditure, and the cardiovascular system.